Home
Anson Funds Management reported a 7% stake in Oncolytics Biotech ONCY · 7,649,050 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 7%
- Last report
- 9.6% · filed 25/02/14
- Shares held
- 7,649,050 sh
- Class
- Common Stock, no par value
- Holder
- Anson Funds Management
- Event date
- 25/09/30
- Filed
- 25/11/14
7% stake · −2.6pp from the last report
- Stake
- 7%
- Last report
- 9.6%
- Since last report
- −2.6pp
Oncolytics Biotech trades, last 26 weeks
What else happened in Oncolytics Biotech around then
Filed or reported within 30 days of the trade day · 25/08/31~25/10/30Anson Funds Management's other 5% stake reports
- Anson Funds Management
5% stake22nd Century Group
5% stake22nd Century Group
XXII
6.7% stake
34,565 sh
6.7% stake
Filed 08/14
- Anson Funds Management
5% stakeNexus Advanced Technologies
5% stakeNexus Advanced Technologies
NXAT
1.3% stake
805,795 sh
1.3% stake
Filed 08/14
- Anson Funds Management
5% stakeVenu Holding
5% stakeVenu Holding
VENU
8.4% stake
4,996,578 sh
8.4% stake
Filed 08/14
- Anson Funds Management
5% stakeSealsq
5% stakeSealsq
LAES
4.9% stake
10,059,050 sh
4.9% stake
Filed 08/14
- Anson Funds Management
5% stakeSono Group
5% stakeSono Group
SSM
9.9% stake
142,000 sh
9.9% stake
Filed 08/14
